Overview
- 6 public-safe observations are available for this inspection.
- 6 structured CFR citations are represented.
- 3 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
30 Jun 2023
21 CFR 211.100(b)
SOPs not followed / documented
Cited by Gretchen L Trendel, Joseph A Piechocki, Mary L Schuckmann
30 Jun 2023
21 CFR 211.130(e)
Packaging line inspection before use
Cited by Gretchen L Trendel, Joseph A Piechocki, Mary L Schuckmann
30 Jun 2023
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Gretchen L Trendel, Joseph A Piechocki, Mary L Schuckmann
30 Jun 2023
21 CFR 211.25(a)
Training , Education , Experience overall
Cited by Gretchen L Trendel, Joseph A Piechocki, Mary L Schuckmann
30 Jun 2023
21 CFR 211.67(b)
Written procedures not established/followed
Cited by Gretchen L Trendel, Joseph A Piechocki, Mary L Schuckmann
Inspected site
LPLegacy Pharmaceutical Packaging, LLCEarth City, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.130(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(a) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 6 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere